Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Identification of a chimeric emm gene and novel emm pattern in currently circulating strains of emm4 Group A Streptococcus.

DebRoy S, Li X, Kalia A, Galloway-Pena J, Shah BJ, Fowler VG, Flores AR, Shelburne SA.

Microb Genom. 2018 Nov 9. doi: 10.1099/mgen.0.000235. [Epub ahead of print]

2.

Editorial: Novel Approaches in Microbiome Analyses and Data Visualization.

Galloway-Peña J, Guindani M.

Front Microbiol. 2018 Sep 27;9:2274. doi: 10.3389/fmicb.2018.02274. eCollection 2018. No abstract available.

3.

Clonal Emergence of Invasive Multidrug-Resistant Staphylococcus epidermidis Deconvoluted via a Combination of Whole-Genome Sequencing and Microbiome Analyses.

Li X, Arias CA, Aitken SL, Galloway Peña J, Panesso D, Chang M, Diaz L, Rios R, Numan Y, Ghaoui S, DebRoy S, Bhatti MM, Simmons DE, Raad I, Hachem R, Folan SA, Sahasarabhojane P, Kalia A, Shelburne SA.

Clin Infect Dis. 2018 Jul 18;67(3):398-406. doi: 10.1093/cid/ciy089.

PMID:
29546356
4.

Associations of inflammation with symptom burden in patients with acute myeloid leukemia.

Lacourt TE, Kavelaars A, Galloway-Peña JR, Sahasrabhojane PV, Shah ND, Futreal A, Kontoyiannis DP, Shelburne SA, Heijnen CJ.

Psychoneuroendocrinology. 2018 Mar;89:203-208. doi: 10.1016/j.psyneuen.2018.01.018.

PMID:
29414033
5.

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, Petaccia de Macedo M, Cotechini T, Kumar T, Chen WS, Reddy SM, Szczepaniak Sloane R, Galloway-Pena J, Jiang H, Chen PL, Shpall EJ, Rezvani K, Alousi AM, Chemaly RF, Shelburne S, Vence LM, Okhuysen PC, Jensen VB, Swennes AG, McAllister F, Marcelo Riquelme Sanchez E, Zhang Y, Le Chatelier E, Zitvogel L, Pons N, Austin-Breneman JL, Haydu LE, Burton EM, Gardner JM, Sirmans E, Hu J, Lazar AJ, Tsujikawa T, Diab A, Tawbi H, Glitza IC, Hwu WJ, Patel SP, Woodman SE, Amaria RN, Davies MA, Gershenwald JE, Hwu P, Lee JE, Zhang J, Coussens LM, Cooper ZA, Futreal PA, Daniel CR, Ajami NJ, Petrosino JF, Tetzlaff MT, Sharma P, Allison JP, Jenq RR, Wargo JA.

Science. 2018 Jan 5;359(6371):97-103. doi: 10.1126/science.aan4236. Epub 2017 Nov 2.

6.

Impact of the Microbiota on Bacterial Infections during Cancer Treatment.

Galloway-Peña J, Brumlow C, Shelburne S.

Trends Microbiol. 2017 Dec;25(12):992-1004. doi: 10.1016/j.tim.2017.06.006. Epub 2017 Jul 17. Review.

PMID:
28728967
7.

Erratum to: An integrative Bayesian Dirichlet-multinomial regression model for the analysis of taxonomic abundances in microbiome data.

Wadsworth WD, Argiento R, Guindani M, Galloway-Pena J, Shelburne SA, Vannucci M.

BMC Bioinformatics. 2017 Mar 23;18(1):185. doi: 10.1186/s12859-017-1606-z. No abstract available.

8.

Can Consideration of the Microbiome Improve Antimicrobial Utilization and Treatment Outcomes in the Oncology Patient?

Galloway-Peña JR, Jenq RR, Shelburne SA.

Clin Cancer Res. 2017 Jul 1;23(13):3263-3268. doi: 10.1158/1078-0432.CCR-16-3173. Epub 2017 Mar 15. Review.

9.

Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients.

Galloway-Peña JR, Smith DP, Sahasrabhojane P, Wadsworth WD, Fellman BM, Ajami NJ, Shpall EJ, Daver N, Guindani M, Petrosino JF, Kontoyiannis DP, Shelburne SA.

Genome Med. 2017 Feb 28;9(1):21. doi: 10.1186/s13073-017-0409-1.

10.

An integrative Bayesian Dirichlet-multinomial regression model for the analysis of taxonomic abundances in microbiome data.

Wadsworth WD, Argiento R, Guindani M, Galloway-Pena J, Shelburne SA, Vannucci M.

BMC Bioinformatics. 2017 Feb 8;18(1):94. doi: 10.1186/s12859-017-1516-0. Erratum in: BMC Bioinformatics. 2017 Mar 23;18(1):185.

11.

A Multi-Serotype Approach Clarifies the Catabolite Control Protein A Regulon in the Major Human Pathogen Group A Streptococcus.

DebRoy S, Saldaña M, Travisany D, Montano A, Galloway-Peña J, Horstmann N, Yao H, González M, Maass A, Latorre M, Shelburne SA.

Sci Rep. 2016 Sep 1;6:32442. doi: 10.1038/srep32442.

12.

The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia.

Galloway-Peña JR, Smith DP, Sahasrabhojane P, Ajami NJ, Wadsworth WD, Daver NG, Chemaly RF, Marsh L, Ghantoji SS, Pemmaraju N, Garcia-Manero G, Rezvani K, Alousi AM, Wargo JA, Shpall EJ, Futreal PA, Guindani M, Petrosino JF, Kontoyiannis DP, Shelburne SA.

Cancer. 2016 Jul 15;122(14):2186-96. doi: 10.1002/cncr.30039. Epub 2016 May 3.

13.

Application of Whole-Genome Sequencing to an Unusual Outbreak of Invasive Group A Streptococcal Disease.

Galloway-Peña J, Clement ME, Sharma Kuinkel BK, Ruffin F, Flores AR, Levinson H, Shelburne SA, Moore Z, Fowler VG Jr.

Open Forum Infect Dis. 2016 Feb 19;3(1):ofw042. doi: 10.1093/ofid/ofw042. eCollection 2016 Jan.

14.

Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis.

Shelburne SA, Ajami NJ, Chibucos MC, Beird HC, Tarrand J, Galloway-Peña J, Albert N, Chemaly RF, Ghantoji SS, Marsh L, Pemmaraju N, Andreeff M, Shpall EJ, Wargo JA, Rezvani K, Alousi A, Bruno VM, Futreal PA, Petrosino JF, Kontoyiannis DP.

PLoS One. 2015 Nov 10;10(11):e0139851. doi: 10.1371/journal.pone.0139851. eCollection 2015.

15.

Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changes.

Flores AR, Galloway-Peña J, Sahasrabhojane P, Saldaña M, Yao H, Su X, Ajami NJ, Holder ME, Petrosino JF, Thompson E, Margarit Y Ros I, Rosini R, Grandi G, Horstmann N, Teatero S, McGeer A, Fittipaldi N, Rappuoli R, Baker CJ, Shelburne SA.

Proc Natl Acad Sci U S A. 2015 May 19;112(20):6431-6. doi: 10.1073/pnas.1504725112. Epub 2015 May 4.

16.

The identification and functional characterization of WxL proteins from Enterococcus faecium reveal surface proteins involved in extracellular matrix interactions.

Galloway-Peña JR, Liang X, Singh KV, Yadav P, Chang C, La Rosa SL, Shelburne S, Ton-That H, Höök M, Murray BE.

J Bacteriol. 2015 Mar;197(5):882-92. doi: 10.1128/JB.02288-14. Epub 2014 Dec 15.

17.

GyrB polymorphisms accurately assign invasive viridans group streptococcal species.

Galloway-Peña J, Sahasrabhojane P, Tarrand J, Han XY, Shelburne SA.

J Clin Microbiol. 2014 Aug;52(8):2905-12. doi: 10.1128/JCM.01068-14. Epub 2014 Jun 4.

18.

Species-level assessment of the molecular basis of fluoroquinolone resistance among viridans group streptococci causing bacteraemia in cancer patients.

Sahasrabhojane P, Galloway-Peña J, Velazquez L, Saldaña M, Horstmann N, Tarrand J, Shelburne SA.

Int J Antimicrob Agents. 2014 Jun;43(6):558-62. doi: 10.1016/j.ijantimicag.2014.01.031. Epub 2014 Mar 27.

PMID:
24721231
19.

Enterococcus faecalis reconfigures its transcriptional regulatory network activation at different copper levels.

Latorre M, Galloway-Peña J, Roh JH, Budinich M, Reyes-Jara A, Murray BE, Maass A, González M.

Metallomics. 2014 Mar;6(3):572-81. doi: 10.1039/c3mt00288h. Epub 2014 Jan 2.

20.

Molecular characterization of an invasive phenotype of group A Streptococcus arising during human infection using whole genome sequencing of multiple isolates from the same patient.

Flores AR, Sahasrabhojane P, Saldaña M, Galloway-Peña J, Olsen RJ, Musser JM, Shelburne SA.

J Infect Dis. 2014 May 15;209(10):1520-3. doi: 10.1093/infdis/jit674. Epub 2013 Dec 4.

21.

Complete genome sequence of Enterococcus faecium strain TX16 and comparative genomic analysis of Enterococcus faecium genomes.

Qin X, Galloway-Peña JR, Sillanpaa J, Roh JH, Nallapareddy SR, Chowdhury S, Bourgogne A, Choudhury T, Muzny DM, Buhay CJ, Ding Y, Dugan-Rocha S, Liu W, Kovar C, Sodergren E, Highlander S, Petrosino JF, Worley KC, Gibbs RA, Weinstock GM, Murray BE.

BMC Microbiol. 2012 Jul 7;12:135. doi: 10.1186/1471-2180-12-135.

22.

Genomic and SNP analyses demonstrate a distant separation of the hospital and community-associated clades of Enterococcus faecium.

Galloway-Peña J, Roh JH, Latorre M, Qin X, Murray BE.

PLoS One. 2012;7(1):e30187. doi: 10.1371/journal.pone.0030187. Epub 2012 Jan 26.

23.

Analysis of PBP5 of early U.S. isolates of Enterococcus faecium: sequence variation alone does not explain increasing ampicillin resistance over time.

Galloway-Peña JR, Rice LB, Murray BE.

Antimicrob Agents Chemother. 2011 Jul;55(7):3272-7. doi: 10.1128/AAC.00099-11. Epub 2011 May 16.

24.

Diversity of the fsr-gelE region of the Enterococcus faecalis genome but conservation in strains with partial deletions of the fsr operon.

Galloway-Peña JR, Bourgogne A, Qin X, Murray BE.

Appl Environ Microbiol. 2011 Jan;77(2):442-51. doi: 10.1128/AEM.00756-10. Epub 2010 Nov 19.

25.

Molecular epidemiology of vancomycin-resistant Enterococcus faecium: a prospective, multicenter study in South American hospitals.

Panesso D, Reyes J, Rincón S, Díaz L, Galloway-Peña J, Zurita J, Carrillo C, Merentes A, Guzmán M, Adachi JA, Murray BE, Arias CA.

J Clin Microbiol. 2010 May;48(5):1562-9. doi: 10.1128/JCM.02526-09. Epub 2010 Mar 10.

26.

Analysis of clonality and antibiotic resistance among early clinical isolates of Enterococcus faecium in the United States.

Galloway-Peña JR, Nallapareddy SR, Arias CA, Eliopoulos GM, Murray BE.

J Infect Dis. 2009 Nov 15;200(10):1566-73. doi: 10.1086/644790.

Supplemental Content

Loading ...
Support Center